Home » 2: Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141) – PMC
2: Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141) – PMC
by Toni Choueri, Moshe Ornstein, Pedro C Barata, Marc Matrana, Jaime Merchan, Craig Gedye, Clara Hwang, Rohit Kumar, Jae Lyun Lee, Yinghui Guan, Mohammad Ghasemi, Syed Quadri, Chris Negro, Jianfen Chen, Paul Foster, Deepti Warad, Bradley A McGregor, Sun Young Rha & Alexandra Drakaki | Oct 10, 2025 | Articles |
